Salidroside orchestrates metabolic reprogramming by regulating the Hif-1α signalling pathway in acute mountain sickness. 2021

Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

BACKGROUND Rhodiola crenulata (Hook. f. et Thoms.) H. Ohba (Crassulaceae) is used to prevent and treat acute mountain sickness. However, the mechanisms underlying its effects on the central nervous system remain unclear. OBJECTIVE To investigate the effect of Rhodiola crenulata on cellular metabolism in the central nervous system. METHODS The viability and Hif-1α levels of microglia and neurons at 5% O2 for 1, 3, 5 and 24 h were examined. We performed the binding of salidroside (Sal), rhodiosin, tyrosol and p-hydroxybenzyl alcohol to Hif-1α, Hif-1α, lactate, oxidative phosphorylation and glycolysis assays. Forty male C57BL/6J mice were divided into control and Sal (25, 50 and 100 mg/kg) groups to measure the levels of Hif-1α and lactate. RESULTS Microglia sensed low oxygen levels earlier than neurons, accompanied by elevated expression of Hif-1α protein. Salidroside, rhodiosin, tyrosol, and p-hydroxybenzyl alcohol decreased BV-2 (IC50=1.93 ± 0.34 mM, 959.74 ± 10.24 μM, 7.47 ± 1.03 and 8.42 ± 1.63 mM) and PC-12 (IC50=6.89 ± 0.57 mM, 159.28 ± 8.89 μM, 8.65 ± 1.20 and 8.64 ± 1.42 mM) viability. They (10 μM) reduced Hif-1α degradation in BV-2 (3.7-, 2.5-, 2.9- and 2.5-fold) and PC-12 cells (2.8-, 2.8-, 2.3- and 2.0-fold) under normoxia. Salidroside increased glycolytic capacity but attenuated oxidative phosphorylation. Salidroside (50 and 100 mg/kg) treatment increased the protein expression of Hif-1α and the release of lactate in the brain tissue of mice. CONCLUSIONS These results suggest that Sal induces metabolic reprogramming by regulating the Hif-1α signalling pathway to activate compensatory responses, which may be the core mechanism underlying the effect of Rhodiola crenulata on the central nervous system.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005960 Glucosides A GLYCOSIDE that is derived from GLUCOSE. Glucoside
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000532 Altitude Sickness Multiple symptoms associated with reduced oxygen at high ALTITUDE. Mountain Sickness,Altitude Hypoxia,Altitude Hypoxias,Hypoxia, Altitude,Sickness, Altitude,Sickness, Mountain

Related Publications

Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
October 2020, European journal of pharmacology,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
January 2022, Frontiers in oncology,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
March 2011, Cancer cell,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
August 2019, Journal of experimental & clinical cancer research : CR,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
June 2022, Journal of cardiovascular pharmacology,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
May 2021, PLoS pathogens,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
May 2023, Biological trace element research,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
January 2005, Wilderness & environmental medicine,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
January 2021, Frontiers in pharmacology,
Xiaoning Yan, and Jie Liu, and Meixia Zhu, and Lirong Liu, and Yijun Chen, and Yinhuan Zhang, and Menghan Feng, and Zhixin Jia, and Hongbin Xiao
July 2024, Bioactive materials,
Copied contents to your clipboard!